PTC Therapeutics Inc. buy Royal Bank of Canada
Start price
05.11.25
/
50%
€61.50
Target price
05.11.26
€71.35
Performance (%)
-2.41%
Price
09.04.26
€60.26
Summary
This prediction is currently active. With a performance of -2.41%, the BUY prediction for PTC Therapeutics Inc. by Royal_Bank_of_Canada is down slightly. This prediction currently runs until 05.11.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| PTC Therapeutics Inc. | 2.701% | 2.701% |
| iShares Core DAX® | 3.075% | 0.488% |
| iShares Nasdaq 100 | 2.876% | 0.081% |
| iShares Nikkei 225® | 5.981% | 3.033% |
| iShares S&P 500 | 2.231% | 0.046% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics (NASDAQ:PTCT) had its price target raised by analysts at Royal Bank Of Canada from $70.00 to $82.00. They now have an "outperform" rating on the stock.
Ratings data for PTCT provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for PTC Therapeutics Inc.
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€36.20
07.05.25
07.05.25
€51.13
07.05.26
07.05.26
65.80%
09.04.26
09.04.26
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€41.60
22.04.25
22.04.25
€56.55
22.04.26
22.04.26
44.86%
09.04.26
09.04.26
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€47.40
18.02.25
18.02.25
€60.28
18.02.26
18.02.26
22.36%
19.02.26
19.02.26
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€49.60
03.12.24
03.12.24
€59.86
03.12.25
03.12.25
28.02%
04.12.25
04.12.25